Bessemer Group Inc. reduced its position in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 34.2% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 567,337 shares of the company's stock after selling 295,309 shares during the quarter. Bessemer Group Inc.'s holdings in Procter & Gamble were worth $82,423,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors have also recently added to or reduced their stakes in the company. Mowery & Schoenfeld Wealth Management LLC acquired a new position in Procter & Gamble in the second quarter worth $26,000. Montgomery Financial Services LLC bought a new stake in Procter & Gamble during the second quarter valued at $28,000. Paladin Partners LLC acquired a new stake in shares of Procter & Gamble during the second quarter worth $29,000. Toews Corp ADV acquired a new stake in shares of Procter & Gamble during the second quarter worth $37,000. Finally, Harborfront Financial Group LLC bought a new position in shares of Procter & Gamble in the 2nd quarter worth about $38,000. Hedge funds and other institutional investors own 65.77% of the company's stock.
Insider Buying and Selling
In related news, CEO Hesham Tohamy Abd El Hak sold 2,250 shares of the company's stock in a transaction on Thursday, November 12th. The shares were sold at an average price of $168.47, for a total value of $379,057.50. Following the completion of the sale, the chief executive officer directly owned 8,968 shares in the company, valued at approximately $1,510,838.96. This represents a 20.06% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, CFO Andre Schulten sold 30,677 shares of the firm's stock in a transaction dated Thursday, November 5th. The shares were sold at an average price of $169.00, for a total value of $5,184,413.00. Following the transaction, the chief financial officer owned 65,618 shares in the company, valued at approximately $11,089,442. This trade represents a 31.86% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders sold 200,006 shares of company stock valued at $32,715,058. 0.23% of the stock is owned by company insiders.
Procter & Gamble Price Performance
Shares of NYSE:PG opened at $172.99 on Tuesday. The company has a market capitalization of $400.96 billion, a PE ratio of 24.35, a price-to-earnings-growth ratio of 4.13 and a beta of 0.36. The company has a debt-to-equity ratio of 0.40, a quick ratio of 0.53 and a current ratio of 0.72. The stock has a fifty day moving average of $154.79 and a 200-day moving average of $150.05. Procter & Gamble Company has a one year low of $137.62 and a one year high of $173.57.
Procter & Gamble (NYSE:PG - Get Free Report) last posted its quarterly earnings data on Thursday, October 22nd. The company reported $2.00 EPS for the quarter, beating analysts' consensus estimates of $1.89 by $0.11. Procter & Gamble had a net margin of 18.23% and a return on equity of 31.02%. The company had revenue of $23.28 billion during the quarter, compared to analyst estimates of $22.80 billion. During the same period in the prior year, the firm earned $1.99 earnings per share. The business's quarterly revenue was up 4.0% on a year-over-year basis. As a group, equities analysts anticipate that Procter & Gamble Company will post 6.99 EPS for the current fiscal year.
Procter & Gamble Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Monday, November 16th. Shareholders of record on Friday, October 23rd were paid a $1.0885 dividend. The ex-dividend date was Friday, October 23rd. This represents a $4.35 dividend on an annualized basis and a yield of 2.5%. Procter & Gamble's payout ratio is 65.51%.
Analyst Upgrades and Downgrades
A number of equities research analysts recently weighed in on PG shares. Barclays boosted their price objective on shares of Procter & Gamble from $152.00 to $165.00 and gave the company an "equal weight" rating in a research report on Monday, October 26th. HSBC lowered Procter & Gamble from a "buy" rating to a "hold" rating and dropped their target price for the stock from $182.00 to $149.00 in a research report on Thursday, July 30th. Freedom Broker raised shares of Procter & Gamble from a "hold" rating to a "buy" rating and set a $176.00 price target for the company in a report on Friday, October 23rd. Argus downgraded shares of Procter & Gamble from a "buy" rating to a "hold" rating in a report on Friday, August 7th. Finally, Citigroup upped their price target on shares of Procter & Gamble from $180.00 to $187.00 and gave the stock a "buy" rating in a research report on Friday, October 23rd. Fifteen investment analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $170.57.
View Our Latest Report on PG
About Procter & Gamble
(
Free Report)
The Procter & Gamble Company is a consumer goods company that develops, manufactures and markets products for everyday use. Founded in 1837 by William Procter and James Gamble, the company is headquartered in Cincinnati, Ohio. Its products span beauty, grooming, health care, fabric and home care, and baby, feminine and family care. Well-known brands include Tide, Pampers, Gillette, Pantene, Olay, Oral-B, Crest, Dawn, Charmin and Bounty. Procter & Gamble sells its products in markets around the world through retail stores, e-commerce platforms and other distribution channels.
Featured Stories
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.